Bristol-Myers Squibb (BMY)
$61.28 1.33 (2.22%)
16:03 EST BMY Stock Quote Delayed 15 Minutes
Previous Close $59.95
Market Cap 100.16B
PE Ratio 107.51
Volume (Avg. Vol.) 14.87M
Day's Range 60.40 - 61.58
52-Week Range 42.48 - 60.86
Dividend & Yield 1.60 (2.61%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
- From InvestorPlace
- From the Web
Goldman Sachs, Bristol-Myers Squibb, Zoom Video and Big Lots were our top stock trades from Friday.
Options trading was buzzing in Bristol-Myers Squibb, Shopify and Walmart stock on Wednesday. Here are the metrics that matter moving forward.
Roku, Bristol-Myers Squibb, Bank of America and Gogo were our top stock trades for Tuesday. Here's a look at the charts.
Billionaire-owned companies perform twice as well as others. Turns out the world's wealthiest and most powerful make for good investors.
Charles Schwab to purchase TD Ameritrade? Let's look at all of the M&A news making noise in the stock market today.
Apple, General Motors, Delta Air Lines, Sarepta and Bristol-Myers Squibb were our top stock trades to watch for Tuesday. Here's what you need to know.
These drug stocks are among the best to buy now because each is making progress in the fight against cancer. Here's what you should know about each.
Apple, Disney, Thor Industries and Bristol-Myers Squibb were our top stock trades from Monday. Here's a look at the charts.
Low P/E stocks often are cheap stocks for a reason. But these 10 stocks to buy have not just reasonable valuations, but strong bull cases.
These 10 stocks don't quite qualify as "set it and forget it" plays. All have some degree of risk. But the risks seem worth taking for the potential rewards, which include near-term income, longer-term growth, and potential capital appreciation.
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.
Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.
Netflix, Amgen, Bristol-Myers Squibb, Aurora Cannabis and Foot Locker are our top stock trades for Tuesday. Here's how to trade them.
Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.
From Simply Wall St
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling short, can easily find investors. Unfortunately, high risk<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bmy/bristol-myers-squibb/news/if-you-like-eps-growth-then-check-out-bristol-myers-squibb-nysebmy-before-its-too-late/">Read More...</a></div>
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!